Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Bicalutamide improves hair density in women safely.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Steroid 12 shows promise as a targeted treatment for prostate cancer by selectively reducing cell growth and increasing cell death.

Propylthiouracil treatment can cause hair loss.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Clofazimine may be effective for treating ashy dermatosis.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.